The Effect of Tilorone Hydrochloride on the Growth of Several Animal Viruses in Tissue Cultures
(Accepted Io December I975)
SUMMARY
Tilorone hydrochloride, at a concentration of Io/zg/ml inhibits the growth of herpes simplex virus type I in BS-C-I cells. The growth of vaccinia virus in BS-C-I ceils is partially inhibited; however, six viruses containing RNA, including four members of the togavirus group grown in chick fibroblasts, are not affected by the drug. The inhibition of the growth of herpes virus by tilorone hydrochloride is greater when the multiplicity of infection is lower than ~ p.f.u./cell and when the drug is added early in the course of infection.
Tilorone hydrochloride, a water-soluble dihydrochloride salt of 2,7,bis [2(diethylamino) ethoxyl] fluoren-9-one (Andrews et al. 1974 ) is an antiviral drug of broad spectrum when given orally to infected mice. Tilorone inhibits infection of mice with Semliki Forest, vesicular stomatitis, encephalomyocarditis, Mengo, influenza A and B and herpes simplex viruses; it also reduces tail lesions by non-lethal doses of vaccinia virus (Kreuger & Mayer, I97o; DeClercq & Merigan, I97I) . The in vivo antiviral activity caused by tilorone was suggested to result from interferon induction (Mayer & Krueger, 197o; DeClercq & Merigan, I97i ; Stringfellow & Glasgow, I972 ) . Tilorone has antitumour activity (Adamson, I97I ; Barker, Rheins & Wilson, 197I ; Roye et al. I97I ; Munson et al. I972) and reduces the activity of DNA polymerases associated with RNA tumour viruses (Chandra, Zunino & Gotz, I972) .
In the present study we wished to follow the effect of tilorone on several animal viruses in tissue culture and to find out whether it is similar to the wide range of in vivo antiviral activity observed previously. It was found that the drug at a concentration of Io/zg]ml does not significantly affect confluent monolayers of BS-C-I cells or chick fibroblasts. The growth rate of seven animal viruses in these cells was examined. Of these, four viruses were of the togaviruses group (Sindbis, Semliki Forest, western and eastern equine encephalitis) and the fifth was poliomyelitis virus type I. Two viruses containing DNA were also tested: vaccinia virus, WR strain, and herpes simplex virus type 1, strain HF. The results shown in Table I demonstrate the significant growth inhibition of herpes simplex virus caused by tilorone hydrochloride 0o/zg/ml). Viruses infected the cell monolayers at the indicated multiplicity of infection, in the absence or presence of Io #g/ml of tilorone hydrochloride. 
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Short communications cells were infected at different virus-to-cell ratios, it was found that the extent of the inhibition of herpes simplex virus by tilorone is more effective as the ratio of multiplicity of infection decreased (Fig. 2) . The difference in the level of the inhibition varies from I log10 (p.f.u.) at a multiplicity of infection of 5 to 2"5 log10 (p.f.u.) at a multiplicity of infection of 0. 3 p.f.u./cell (Fig. 2) . The time of addition of tilorone to the culture is also an important factor of the inhibition. Addition of tilorone before infection or shortly afterwards results in a greater inhibition than by its addition at 3 or 6 h after infection.
The inhibition of herpes simplex virus growth by tilorone hydrochloride raises the question whether non-infectious virus particles are made under these conditions. Herpes simplex virions can be located at a definite band in sucrose gradient, following high speed centrifugation. We could not observe such a virus band when tilorone was present in the infected culture, indicating that non-infectious particles were not formed under these conditions.
The results presented here suggest that the antiviral activity of tilorone hydrochloride in tissue cultures is narrow as compared to its activity in mice. The drug inhibits very efficiently the growth of herpes simplex virus and partially the growth of vaccinia virus. However, viruses which are known to be more sensitive to interferon than herpes virus, such as togaviruses, were almost unaffected by the drug. This may suggest that the antiviral activity shown in tissue culture is not caused by interferon induction. This is in agreement with the results obtained in mice by Giron, Schmidt & Pindak (I97z) , who did not find a correlation between interferon induction and protection from viral infection. Further studies to clarify the mechanism by which tilorone hydrochloride inhibits herpes virus growth in BS-C-I cells are in progress.
